A new clinical trial demonstrates that leveraging prior cardiovascular imaging data can boost antihypertensive treatment ...

Results from the Phase III ZENITH trial show that Winrevair lowered the risk of all-cause death, lung transplantation, and ...

That is the conclusion of the Advance-HTN study reported at the American College of Cardiology (ACC) meeting, which found ...

Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a pioneering Ripasudil-Timolol combination therapy for ...

Hypertension reduces podocyte density, weakens filtration, and increases the risk of chronic kidney disease (CKD). Early ...

A new study by investigators at Mass General Brigham shows that clues about hypertension may be buried in electronic health ...

The investigational aldosterone synthase inhibitor lorundrostat effectively lowered 24-hour BP for adults with well-treated, ...

After giving birth, you don’t have to only worry about sleepless nights and breastfeeding issues. There can also be ...

Often developing within days or weeks after delivery, high blood pressure during the postpartum period can be asymptomatic ...

Akums launches novel ripasudil+timolol combination for glaucoma and ocular hypertension: Our Bureau, Bengaluru Tuesday, April 1, 2025, 16:40 Hrs [IST] Akums Drugs & Pharmaceutical ...